Revenue: The sum of all revenue fields included for a company's operating activities.
Iovance Biotherapeutics, Inc. (IOVA) had Revenue of $86.77M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$86.77M |
$-71.90M |
|
$28.30M |
|
$58.47M |
|
$160.23M |
|
$-73.46M |
|
$1.74M |
|
$-71.72M |
|
$-71.72M |
|
$-71.90M |
|
$-71.90M |
|
$-71.90M |
|
$-71.90M |
|
$-73.46M |
|
$-62.16M |
|
357.35M |
|
357.35M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$442.69M |
|
$131.11M |
|
$470.48M |
|
$913.17M |
|
$138.36M |
|
-- |
|
$76.23M |
|
$214.59M |
|
$698.58M |
|
$419.26M |
|
$698.58M |
|
411.94M |
|
| Cash Flow Statement Financials | |
$-302.41M |
|
$47.50M |
|
$300.77M |
|
$122.05M |
|
$169.06M |
|
$47.01M |
|
$61.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.20 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
67.38% |
|
-84.66% |
|
-84.66% |
|
-- |
|
-82.65% |
|
-82.87% |
|
$-336.24M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.55 |
|
1.05 |
|
85.52 |
|
-10.29% |
|
-17.15% |
|
-7.87% |
|
-10.29% |
|
$1.70 |
|
$-0.94 |
|
$-0.85 |
|